Did you know that 86% of GLP-1 users experience GI side effects?

GLP-1 medications are changing the conversation around obesity and metabolic care—but for many, GI symptoms derail treatment.

What we cover:

• Why over half of new GLP-1 users already have GI symptoms.
• How pairing GLP-1s with expert GI care boosts tolerance, adherence, and ROI.
• What makes Cylinder different: only 6% of our members stop GLP-1s due to side effects

Speakers:
  - Dena Bravata, MD, MS, Co-founder, Lyra Health
  - Hau Liu, MD, MBA, MPH, Chief Medical Officer, Cylinder
  - Yael Horwitz, MPH, Senior Manager, Clinical Product, Cylinder

Watch the webinar now for actionable ideas to help you optimize GLP-1 outcomes.